Nefazodone and Fosaprepitant: Interaction Details

Brand names
Fosaprepitant
EmendFocinvez
Nefazodone
Serzone
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Fosaprepitant

Brand names
  • Emend
  • Focinvez

We don't have a drug information page for Fosaprepitant yet. Have a question about Fosaprepitant? Ask a pharmacist, free →

What Happens When You Take Nefazodone With Fosaprepitant

What can happen when they are taken together (rated Major)

Increased aprepitant or fosaprepitant ( of aprepitant) exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving aprepitant or fosaprepitant (a prodrug of aprepitant), both , together with a strong CYP3A4 should be avoided, since exposure to aprepitant or fosaprepitant may rise and the likelihood of adverse effects may increase.12 In a study in which ketoconazole, a strong CYP3A4 inhibitor, was given at 400 mg/day for 10 days, a single oral 125 mg dose of aprepitant on day 5 produced an approximately 5-fold increase in aprepitant , and the mean terminal of aprepitant was prolonged roughly 3-fold.2

The Nefazodone and Fosaprepitant Interaction, Explained

Nefazodone can raise the amount of aprepitant in your body. Fosaprepitant (Emend Injection, Focinvez) is given by IV to prevent nausea and vomiting, often around chemotherapy. Your body converts it to aprepitant, and the liver enzyme helps clear it. Nefazodone is a strong blocker of that enzyme, so aprepitant can build up and stay longer. That may mean more side effects, such as tiredness, dizziness, hiccups, or constipation.

Do not stop or change anything on your own. Tell your pharmacist and prescriber about both medicines so your care team can decide the safest plan for you.

Mechanism: Nefazodone is a strong . It inhibits CYP3A4-mediated of aprepitant, the active moiety. Fosaprepitant is a rapidly converted to aprepitant by phosphatases (not -dependent), so the CYP3A4 affects the active drug and increases exposure.

  • Magnitude: With ketoconazole (a strong CYP3A4 inhibitor), aprepitant rose about 5-fold and about 3-fold. Nefazodone-specific data are not cited.
  • Onset: Delayed. Evidence: Probable. Severity: Major.
  • Management: Avoid . If it cannot be avoided, consider an alternative antiemetic or antidepressant and monitor for aprepitant adverse effects.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Nefazodone and Fosaprepitant Interact

The likely mechanism

of -mediated of aprepitant

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Nefazodone and Fosaprepitant Interaction

The documented advice is to avoid using these two medicines together. Your care team will usually review your full medication list and may choose a different option for nausea prevention or for depression. If both are considered necessary, your team may monitor you more closely for side effects.

  • Keep taking your medicines as prescribed until your prescriber advises otherwise.
  • Tell your pharmacist and prescriber that you take nefazodone before any fosaprepitant dose.
  • Report unusual tiredness, dizziness, or other new symptoms.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Nefazodone or Fosaprepitant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: FOCINVEZ intravenous injection, fosaprepitant intravenous injection

    A single oral 125 mg dose of aprepitant was given on day 5 of a 10 day course of ketoconazole 400 mg/day, ketoconazole being a strong . Under these conditions, the of aprepitant rose roughly 5-fold, and its mean terminal was prolonged approximately 3-fold.2

Nefazodone and Fosaprepitant: Common Questions

How serious is the Nefazodone and Fosaprepitant interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Nefazodone and Fosaprepitant interaction managed?

The documented advice is to avoid using these two medicines together. Your care team will usually review your full medication list and may choose a different option for nausea prevention or for depression. If both are considered necessary, your team may monitor you more closely for side effects. Keep taking your medicines as prescribed until your prescriber advises otherwise. Tell your pharmacist… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Nefazodone and Fosaprepitant Interaction

Ask in your own words about taking Nefazodone and Fosaprepitant together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: EMEND(R) intravenous injection, fosaprepitant intravenous injection. Merck Sharp & Dohme Corp (per FDA), Whitehouse Station, NJ, 2022. DailyMed
  2. Product Information: FOCINVEZ intravenous injection, fosaprepitant intravenous injection. Spes Pharmaceuticals Inc (per FDA), North Brunswick, NJ, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Nefazodone and Fosaprepitant

Also serious with Fosaprepitant

Also serious with Nefazodone

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Fosaprepitant

With Nefazodone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.